CEVR analyzes the value of strategies to improve health and health care.

About Us

News

In remembrance of John Iglehart
In remembrance of John Iglehart By Peter J. Neumann The passing of John Iglehart, the Founding Editor of Health Affairs, and a monumental figure in t...
Read more June 23, 2025
CEVR Welcomes 2025 CEA Registry Summer Fellows
CEVR Welcomes 2025 CEA Registry Summer Fellows CEVR is thrilled to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship program,...
Read more June 16, 2025
Join Our Team: CEVR is Hiring an Administrative Assistant II
Job Profile Summary ​This role focuses on providing administrative and business support to the organization in order to achieve operational goals. In...
Read more June 12, 2025
View All News Items

Events

CEVR Health Policy Seminar with Nathaniel Hendrix, PhD, PharmD
Learn more
2:00–3:00 on June 17, 2025
CEVR Health Policy Seminar with Noemi Kreif, PhD
Learn more
4:00–5:00 on May 6, 2025
CEVR Health Policy Seminar with Xin Hu, PhD, MSPH
Learn more
2:00–3:00 on April 22, 2025
View All Events

Recent Publications

Health Affairs
Drug coverage policies and clinical guidelines alignment: Most coverage decisions include additional restrictions
View publication
July 7, 2025
Frontiers in Pharmacology
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
View publication
July 2, 2025
Value in Health
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States
View publication
June 19, 2025
Value in Health
US Drug Pricing Patterns Before Loss of Exclusivity
View publication
April 8, 2025
Health Affairs Scholar
An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022
View publication
April 4, 2025
JMCP
Assessing variation in US payer coverage of anti–vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edema
View publication
April 3, 2025
Health Affairs Forefront
Bringing Systems Thinking To Drug Value Assessment
View publication
March 11, 2025
View All Publications

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.

CEA Registry

The CEA Registry is a comprehensive database of 9,080 cost-utility analyses on a wide variety of diseases and treatments.

View Registry

Global Health CEA Registry

The GH CEA Registry is the first comprehensive database to compile articles utilizing the “cost-per-DALY averted” metric to measure the efficacy of health interventions.

View Registry

SPEC Database

The Specialty Drug Evidence and Coverage (SPEC) Database is a new data resource developed with the goal of providing an empirical basis to commercial payer specialty drug coverage.

View Database
Learn About Our Databases